webinar register page

Webinar banner
Multiparticulates Part 8: Scale up considerations on the Wurster (bottomspray) fluidized bed process


Sep 8, 2021 02:43 PM

* Required information


Dr. Norbert Poellinger
Head of Technology Development @Glatt Pharmaceutical Services
Norbert Poellinger is heading the Technology Development unit. Until 2018, he was responsible for Development and Manufacturing Services Group at Glatt Pharmaceutical Services which included Pharmaceutical Development, Manufacturing, Quality Control, Quality Assurance and Plant Engineering. He studied pharmaceutical sciences at the University of Erlangen, Germany and received a PhD degree in Pharmaceutical Technology. Currently, the recently formed Glatt Pharmaceutical Services GmbH & Co.KG focuses on controlled release and taste masked multiparticulates including minitablets and tablets. Drug products for the paediatric and geriatric population are of particular interest. Logistic services have become a new service opportunity of Glatt